Hospitals need to start preparing for major changes to price transparency requirements, according to the 2024 Outpatient Prospective Payment System (OPPS) final rule, released November 2. The final rule details a slew of changes to price transparency compliance along with reimbursement changes...Read More »
CMS is moving forward with its proposals to address unlawful payment reductions to 340B drug reimbursement, according to a final rule released November 2. The final rule keeps most of the provisions of the proposed rule intact with only a few adjustments based on commenter feedback.Read More »
Pharmacy revenue generally is a top revenue driver at most organizations, but too often it’s treated similarly to other service lines within the organization that don’t have nearly the same charging complexities and nuances nor the impact to the bottom line...Read More »
